Celularity Inc.
CELU
$2.04
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -49.80% | -36.98% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -49.80% | -36.98% | |||
| Cost of Revenue | 47.50% | -51.60% | |||
| Gross Profit | -93.72% | -27.04% | |||
| SG&A Expenses | -11.41% | -11.18% | |||
| Depreciation & Amortization | 1.09% | -2.13% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.42% | -20.62% | |||
| Operating Income | -51.29% | -10.69% | |||
| Income Before Tax | -24.15% | -48.60% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -24.15% | -48.60% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -24.15% | -48.60% | |||
| EBIT | -51.29% | -10.69% | |||
| EBITDA | -62.16% | -13.89% | |||
| EPS Basic | -21.62% | -40.78% | |||
| Normalized Basic EPS | -64.01% | -2.11% | |||
| EPS Diluted | -21.62% | -40.78% | |||
| Normalized Diluted EPS | -64.01% | -2.11% | |||
| Average Basic Shares Outstanding | 2.08% | 5.55% | |||
| Average Diluted Shares Outstanding | 2.08% | 5.55% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||